What We're Reading: Page 311
Industry reads hand-picked by our editors
Jan 25, 2017
-
The Hill
2016 FDA drug approval numbers — what can Trump conclude?
-
EP Vantage
Life for kinase inhibitors in an immuno-oncology world
-
Crain's Chicago Business
How to make sure participants make it to clinical trials? Enter Lyft
-
Science
The Hollywood analogy
Jan 24, 2017
-
The New York Times
The fight Trump faces over drug prices
-
The Associated Press
Maine bill seeks to curtail drug company payments to doctors
-
Forbes
Keep politics out of science, says departing FDA chief
-
Quartz
A US town with a population of 105,000 is suing a drugmaker for ignoring illegal OxyContin sales
Jan 23, 2017
-
Kaiser Health News
Trump’s HHS pick favored drugmakers, device makers and doctors
-
The Telegraph
Small drug companies grow as big pharma outsources
-
Reuters
Egypt's military to enter pharmaceutical industry
-
The Boston Globe
How a biotech startup rose, and then fell
Jan 20, 2017
-
The Washington Post
NIH Director Francis Collins to stay in his post for now
-
Bloomberg
Obamacare replacement may improve patient access, Novartis says
-
Scientific American
Proposed presidential autism–vaccine panel could help spread disease
-
ProPublica
When a study cast doubt on a heart pill, the drug company turned to Tom Price
Jan 19, 2017
-
Nature
Cancer reproducibility project releases first results
-
Reuters UK
GSK grabs Astra executive to replace pharma head
-
The Wall Street Journal
Mystery fungus sparks NIH crisis, imperiling trials, patients and its boss
Jan 18, 2017
Jan 17, 2017
-
The Washington Post
Trump vows 'insurance for everybody' in Obamacare replacement plan
-
Kaiser Health News
Drugmakers manipulate orphan drug rules to create prized monopolies
-
The New York Times
Australian drug maker has low profile but powerful backers in Washington
-
Reuters
Alcobra to stop testing sole drug for ADHD after study fails
Previous
